COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment.

Autor: Salisbury D; Programme for Global Health, Royal Institute of International Affairs, Chatham House, London, United Kingdom., Lazarus JV; Graduate School of Public Health and Health Policy (CUNY SPH), City University of New York, New York, NY, United States.; Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain., Waite N; School of Pharmacy, University of Waterloo, Ontario, ON, Canada., Lehmann C; Department of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany., Sri Bhashyam S; ICON Insights, Evidence and Value-Patient Centered Outcomes, Reading, United Kingdom., de la Cruz M; ICON Insights, Evidence and Value-Patient Centered Outcomes, Raleigh, NC, United States., Hahn B; Novavax, Inc, Gaithersburg, MD, United States., Rousculp MD; Novavax, Inc, Gaithersburg, MD, United States., Bonanni P; Department of Health Services, University of Florence, Florence, Italy.

Publikováno v: JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Oct 16; Vol. 10, pp. e57242. Date of Electronic Publication: 2024 Oct 16.

MSR21 Methodological Aspects of a COVID-19 Vaccine Discrete Choice Experiment Survey in Canada, Germany, UK, and US General Populations

Autor: Sri Bhashyam, S., Lewis, H.B., Rousculp, M., Shane, L.G., d la Cruz, M., Galinsky, J., Demchuk, K., Lehmann, C., Waite, N., Lazarus, J., Bonanni, P., Salisbury, D.

Publikováno v: In Value in Health December 2023 26(12) Supplement:S397-S397

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2.

Autor: Patel, Anish¹ (AUTHOR) anish.patel@novartis.com, Toro, Walter¹ (AUTHOR), Bourke, Siobhan² (AUTHOR), Oluboyede, Yemi³ (AUTHOR), Barbier, Sylvaine⁴ (AUTHOR), Bogoeva, Nataliya⁵ (AUTHOR), Reyna, Sandra P.¹ (AUTHOR), Dabbous, Omar¹ (AUTHOR)

Publikováno v: PLoS ONE. 10/21/2024, Vol. 19 Issue 10, p1-20. 20p.

Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis.

Autor: Tervonen T; Evidera, London, UK. Electronic address: tommi.tervonen@evidera.com., Ustyugova A; Boehringer Ingelheim GmBH, Ingelheim, Germany., Sri Bhashyam S; Evidera, London, UK., Lip GYH; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Verdecchia P; Hospital of Assisi, Assisi, Italy., Kwan R; Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario, Canada., Gropper S; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Heinrich-Nols J; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Marsh K; Evidera, London, UK.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2017 Dec; Vol. 20 (10), pp. 1394-1402. Date of Electronic Publication: 2017 Jul 15.